Performance of Osteoporosis Risk Assessment Tools in Iranian Postmenopausal Women

AUTHORS

MH Dabbaghmanesh 1 , R Sabet 1 , A Aria 1 , GR R Omrani 2 , *

1 Endocrine and Metabolism Research Center, Nemazee Hospital, IR.Iran

2 Endocrine and Metabolism Research Center, Nemazee Hospital, [email protected], IR.Iran

How to Cite: Dabbaghmanesh M, Sabet R, Aria A, R Omrani G. Performance of Osteoporosis Risk Assessment Tools in Iranian Postmenopausal Women, Int J Endocrinol Metab. Online ahead of Print ; 5(1):26-32.

ARTICLE INFORMATION

International Journal of Endocrinology and Metabolism: 5 (1); 26-32
Article Type: Original Article
Received: May 8, 2006
Accepted: December 1, 2006
READ FULL TEXT

Abstract

Risk indices have been developed to identify postmenopausal women at risk of low bone mineral density who need to undergo BMD test-ing. The aim of study was to compare perform-ance of three decision rules for identifying women with primary osteoporosis in an Iranian post-menopausal population. Materials and Methods: Three osteoporosis risk indices- the osteoporosis self assessment tool (OST), the osteoporosis risk assessment instru-ment (ORAI), and body weight criterion were calculated for 5573 out patients without risk fac-tors for secondary osteoporosis or receiving ac-tive bone medication. BMD at spine and femoral neck were measured via dual x-ray absorpti-omety. The sensitivity, specificity, positive pre-dictive value, negative predicative value and area under receiver operating characteristic curve to identify those with osteoporosis were deter-mined for each decision rule; these were then compared. Results: The sensitivity of these risk indices ranged from 70% to 84/1% and specificity from 44.6 to 65.6%. The area under curve (ROC) in identifying patients with osteoporosis were sig-nificantly better for OST (0.75) and ORAI (0.74) compared with the body weight criteria (0.66). The negative predicative values ranged from 80 to 93%, while positive predication values ranged from 33 to 45%. Conclusion: Our data provide evidence for the application of OST, ORAI as useful clinical tools in making decision about which women need to be referred for BMD testing; more evidence however is needed to confirm validity of the body weight criterion. Of the three tools evalu-ated, the OST is the simplest and has the best potential for use in clinical practice.

© 0, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: